Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human alpha Synuclein ELISA Kit (AC3616)
Cat.#: ASET-2205
Specifications
Description Human alpha Synuclein ELISA Kit allows for the in vitro quantitative determination of human alpha Synuclein concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.375 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 15.625-1000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1792 Human PGRPS ELISA Kit (AC3203) Quantitative inquiry ASET-1967 Human Estrogen Receptor beta ELISA Kit (AC3378) Quantitative inquiry ASET-1064 Mouse TSH beta ELISA Kit (AC2475) Quantitative inquiry ASET-1776 Human Synapsin I ELISA Kit (AC3187) Quantitative inquiry ASET-1622 Human ASRGL1 ELISA Kit (AC3033) Quantitative inquiry ASET-1943 Mouse NK-2R ELISA Kit (AC3354) Quantitative inquiry ASET-1222 Human PDE7B ELISA Kit (AC2633) Quantitative inquiry ASET-2522 Human Nogo ELISA Kit (AC3933) Quantitative inquiry ASET-1718 Mouse CDNF ELISA Kit (AC3129) Quantitative inquiry ASET-1095 Human Notch2 ELISA Kit (AC2506) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket